C47-32136-63852
6 vaccinations
11 coded responses
67 check-ins
9 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 275 / NC
- Registered
- 2021-02-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Dose 1 — Pfizer-BioNTech
-
2021-02-15
Registered in v-safe
- 2021-02-15
- 2021-02-17
-
2021-02-18
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: No residual effects at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-26
-
2021-03-05
Dose 2 — Pfizer-BioNTech
- 2021-03-05
-
2021-03-07
Survey response — days 1–6 daily, dose 2MedDRA: Body temperature decreased — Feeling: Good · Site: Pain, Swelling · HeadacheFree text: Temperature was much lower than normal yesterday morning (both oral and rectal). Recovered by the afternoon.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-06-04
- 2021-09-03
-
2021-09-30
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
-
2021-10-07
Survey response — day 7, dose 3MedDRA: Oropharyngeal pain — Feeling: Fair · Fatigue or tirednessFree text: Minor sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
-
2021-12-30
Survey response — 3 months, dose 3MedDRA: Arthralgia, Headache, Myalgia, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache and mild joint and muscle pain. Negative COVID-19 tests. Lasted about 4-5 days.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-31
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold like symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-05
Dose 4 — Moderna
- 2022-04-08
- 2022-04-09
- 2022-04-10
- 2022-04-11
- 2022-04-12
-
2022-04-19
Survey response — day 14, dose 4MedDRA: Eye pruritus, Headache, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: Itchy eyes, headache. Associated with allergiesMedDRA releases: 2024-11 · check-in free text available
- 2022-04-26
- 2022-05-05
- 2022-05-10
- 2022-05-17
-
2022-07-05
Survey response — 3 months, dose 4MedDRA: Arthralgia, Fatigue, Influenza like illness, Myalgia, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Flu-like symptoms with moderate fever, congestion, minor muscle and joint aches, fatigue. All COVID-19 tests were negativeMedDRA releases: 2024-11 · check-in free text available
-
2022-09-08
Dose 5 — Pfizer-BioNTechCo-administered: Shingles
- 2022-09-09
- 2022-09-10
- 2022-09-11
- 2022-09-17
- 2022-09-24
- 2022-09-29
-
2022-10-06
Survey response — day 28, dose 5MedDRA: Fatigue, Oropharyngeal pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had a day with a sore throat and fatigued. Lasted a single day.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-13
-
2022-10-20
Survey response — day 42, dose 5MedDRA: Oropharyngeal pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat. Lasted only one day.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-10
-
2023-03-09
Survey response — 6 months, dose 5MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-05-11
Dose 6 — Pfizer-BioNTech
- 2023-05-13
- 2023-05-14
- 2023-05-15
- 2023-05-16
- 2023-05-17
- 2023-05-18
- 2023-05-25
- 2023-06-01
-
2023-06-08
Survey response — day 28, dose 6MedDRA: Tendonitis — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-06-16
- 2023-06-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Pfizer-BioNTech | |
| 2 | 2021-03-05 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-05 | Moderna | No |
| 5 | 2022-09-08 | Pfizer-BioNTech | Shingles |
| 6 | 2023-05-11 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): No residual effects at the injection site
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Temperature was much lower than normal yesterday morning (both oral and rectal). Recovered by the afternoon.
Release 10 — day 7, dose 3
Systemic reaction (other): Minor sore throat
Release 10 — 3 months, dose 3
Symptoms: Headache and mild joint and muscle pain. Negative COVID-19 tests. Lasted about 4-5 days.
Release 11 — 6 months, dose 3
Symptoms: Cold like symptoms
Release 11 — day 14, dose 4
Symptoms: Itchy eyes, headache. Associated with allergies
Release 12 — 3 months, dose 4
Symptoms: Flu-like symptoms with moderate fever, congestion, minor muscle and joint aches, fatigue. All COVID-19 tests were negative
Release 12 — day 28, dose 5
Symptoms: Had a day with a sore throat and fatigued. Lasted a single day.
Release 12 — day 42, dose 5
Symptoms: Sore throat. Lasted only one day.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Eye pruritus | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Tendonitis | · | · | ✓ |
| SRO | Body temperature decreased | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release